arrow
返回
C

Catherine Thiéblemont

universite paris cite

100H指数
886论文数
3.6W被引数
收录论文 192
发表时间
Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?更正:在大型B细胞淋巴瘤的高风险患者中,术前修改的淋巴细胞清除能否改善预后?
err2026-03-02
err0
errOAAI
errMarta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Côme Bommier; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Roberta Di Blasi; Sophie Caillat-Zucman; Catherine Thieblemont
err分享
err收藏
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?改良的淋巴细胞清除术在大型B细胞淋巴瘤的高风险患者中能否改善预后?
err2026-01-08
err0
errOAAI
errMarta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Bommier Côme; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Di Blasi Roberta; Sophie Caillat-Zucman; Catherine Thieblemont
err分享
err收藏
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group抗CD19 CAR-T细胞疗法失败后套细胞淋巴瘤患者的结局:Descar-T研究(Lysa集团)
err2025-10-03
err0
errOAAI
errMarion Aymard; Morgane Cheminant; Roch Houot; Anne Cuozzo; Elodie Gat; Catherine Thieblemont; Laure Ricard; Louise Roulin; Krimo Bouabdallah; Violaine Safar; Stephanie Guidez; Amandine Fayard; Gabriel Brisou; Loic Ysebaert; Olivier Hermine; Benoît Tessoulin; Charles Herbaux; Steven Le Gouill; Clementine Sarkozy
err分享
err收藏
PROs versus clinician-reported adverse events in a large clinical trial: findings from the Phase 3 POLARIX study患者报告结果(PROs)与临床医生报告的不良事件在大型临床试验中的比较:来自III期POLARIX研究的结果
errBlood
IF23.1
err2025-09-29
err0
errOAAI
errCarrie Thompson; Marek Trněný; Franck Morschhauser; Gilles Salles; Patrick M. Reagan; Mark Hertzberg; Huilai Zhang; Catherine Thieblemont; Bei Hu; Gustavo Fonseca; Won Seog Kim; Maurizio Martelli; Amitkumar Mehta; Avrita Singh; Mark Yan; Jamie Hirata; Matthew Sugidono; Calvin Lee; Jeff P. Sharman; Neha Mehta-Shah; Christopher R. Flowers; Hervé Tilly; Neil Chua; René-Olivier Casasnovas; Fiona Miall; Tae Min Kim; Xavier Cheng-Hong Tsai; Sunita Nasta; Seung Tae Lee; Jonathan W. Friedberg
err分享
err收藏
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up弥漫大B细胞淋巴瘤(LBCL):EHA 诊断、治疗和随访临床实践指南
err2025-09-23
err0
errOAAI
errCatherine Thieblemont; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Natacha Bolanos; Maja Marković; Jean-Philippe Jais; Florence Broussais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Marie-José Kersten
err分享
err收藏
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe弥合欧洲大B细胞淋巴瘤疗法在临床试验可及性和报销方面的差距
err2025-09-23
err0
errOAAI
errFlorence Broussais; Elise Pennings; Natacha Bolanos; Lorna Warwick; Robin Doeswijk; Gauthier Quinonez; Andrii Lebeda; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Jean-Philippe Jais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Catherine Thieblemont; Marie Jose Kersten
err分享
err收藏
Routine Prophylaxis with Levetiracetam offers no benefit in CD19 CAR-T for LBCL: a Multicenter Propensity-matched Study常规使用左乙拉西坦进行预防对LBCL的CD19 CAR-T治疗无益:一项多中心倾向性匹配研究
err2025-08-11
err0
errOAAI
errEugenio Galli; Roberta Di Blasi; Alice Di Rocco; Caterina Cristinelli; Ilaria Pansini; Côme Bommier; Alessandro Corrente; Ilenia De Bernardis; Marcello Viscovo; Stefan Hohaus; Anna Modoni; Federica Sorà; Patrizia Chiusolo; Maurizio Martelli; Simona Sica; Catherine Thieblemont
err分享
err收藏
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II StudyBrentuximab Vedotin联合Gemcitabine治疗复发或难治性外周T细胞淋巴瘤:一项LYSA II期研究
err2025-08-06
err0
errOAAI
errOlivier Tournilhac; Kamal Bouabdallah; Solene Lecolant; Maya Hacini; Kamel Laribi; Sébastien Bailly; Thibaut Belmondo; Marie Maerevoet; Loic Ysebaert; Stephanie Guidez; Steven Le Gouill; Christophe Bonnet; Marc André; Jehan Dupuis; Catherine Thieblemont; Emmanuel Bachy; Nicolas Daguindau; Franck Morschhauser; Sabine Tricot; Charline Moulin; Anne Banos; Roch Houot; Adrien Chauchet; Emmanuel Gyan; Guillaume Cartron; Hassan Farhat; Vincent Camus; Bernard Drenou; Hacene Zerazhi; David Sibon; Emmanuelle Nicolas-Virelizier; Caroline Delette; Sylvia Snauwaert; Sarah Bailly; Richard Delarue; Sylvain Carras; Albane Ledoux-Pilon; Marie Parrens; Samuel Griolet; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Gandhi Laurent Damaj
err分享
err收藏
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†淋巴瘤:ESMO临床实践指南——诊断、治疗与随访†
err2025-08-05
err0
PREAI
errT.A. Eyre; K. Cwynarski; F. d'Amore; L. de Leval; M. Dreyling; D.A. Eichenauer; A.J.M. Ferreri; E. Giné; M.J. Kersten; M. Ladetto; L. Specht; C. Thieblemont; J. Walewski; E. Zucca; M. Jerkeman
err分享
err收藏
Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy异基因干细胞移植在经历帕博利珠单抗治疗后的血液系统恶性肿瘤患者中的应用
err2025-06-01
err0
PREAI
errJohn Kuruvilla; Philippe Armand; Alex F. Herrera; Vincent Ribrag; Catherine Thieblemont; Bastian von Tresckow; Guoqing Wang; Patricia Marinello; Samhita Chakraborty; Robert Orlowski; Pier Luigi Zinzani
err分享
err收藏
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalitionCAR T细胞治疗原发性或继发性中枢神经系统淋巴瘤患者的疗效和安全性: 代表EBMT和GoCART联盟的研究
err2025-05-21
err0
errOAAI
errSaidy, Anna Ossami; Peczynski, Christophe; Thieblemont, Catherine; Daskalakis, Michael; Wehrli, Marc; Beauvais, David; Finke, Juergen; Schorb, Elisabeth; Vandenberghe, Peter; Berning, Philipp; Stelljes, Matthias; Ayuk, Francis; Ram, Ron; Von Bonin, Malte; Dreger, Peter; Bethge, Wolfgang; Kuhnl, Andrea; Jost, Lasse; Stoelzel, Friedrich; von Tresckow, Bastian; Renner, Christoph; Fuhrmann, Stephan; Galimard, Jacques-Emmanuelle; Michel, Eva; Bazarbachi, Ali; Balari, Anna Sureda; Schmitz, Norbert; Glass, Bertram
err分享
err收藏
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomasTRANSCAR:CD19 CAR T细胞疗法在复发/难治性转化型惰性淋巴瘤中的真实世界疗效
err2025-05-05
err0
errOAAI
errPierre Stephan; Roberta Di Blasi; Louise Roulin; Jean Galtier; Julien Calvani; Véronique Meignin; Marie Donzel; Alexandra Traverse-Glehen; Elsa Poullot; Marie Parrens; Vivien Dupont; Alexandra Marquet; Steven Le Gouill; Roch Houot; Francois-Xavier Gros; François Lemonnier; Emmanuel Bachy; Catherine Thieblemont; Pierre Sesques
err分享
err收藏
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma新型溴结构域和-extra-terminal结构域抑制剂BI 894999在晚期实体瘤或弥漫性大B细胞淋巴瘤患者中的Ia/Ib期研究最终结果
err2025-05-01
err0
PREAI
errLauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schoffski, P.
err分享
err收藏
T cell malignancies after CAR T cell therapy in the DESCAR-T registry (vol 31, pg 1130, 2025)CAR T细胞疗法后T细胞恶性肿瘤在DESCAR-T登记研究中的情况(卷31,页1130,2025)
err2025-04-25
err0
PREAI
errDulery, Remy; Guiraud, Vincent; Choquet, Sylvain; Thieblemont, Catherine; Bachy, Emmanuel; Barete, Stephane; Todesco, Eve; Arnulf, Bertrand; Boissel, Nicolas; Baruchel, Andre; Bay, Jacques-Olivier; Le Gouill, Steven; Houot, Roch
err分享
err收藏
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA studyGlofitamab在难治性或复发性弥漫性大B细胞淋巴瘤中的应用:一项在CAR-T细胞疗法失败后的II期LYSA研究
err2025-04-03
err0
PREAI
errCartron, Guillaume; Houot, Roch; Al Tabaa, Yassine; Le Bras, Fabien; Ysebaert, Loic; Choquet, Sylvain; Jardin, Fabrice; Bay, Jacques-Olivier; Gros, Francois-Xavier; Morschhauser, Franck; Casasnovas, Olivier; Gastinne, Thomas; Thieblemont, Catherine; Joris, Magalie; Ricard, Laure; Regny, Caroline; La Rochelle, Laurianne Drieu; Feugier, Pierre; Marcais, Ambroise; Griolet, Samuel; Laurent, Camille; Sesques, Pierre
err分享
err收藏
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (vol 109, pg 2297, 2024)苯达莫司汀和利妥昔单抗作为症状性脾 marginal zone 淋巴瘤的一线治疗:长期结局及早期不可测量微小残留病获得的影响——来自 BRISMA/IELSG36 期 II 研究的数据(vol 109, pg 2297, 2024)
err2025-04-01
err0
errOAAI
errIannitto, Emilio; Ferrero, Simone; Bommier, Come; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine
err分享
err收藏
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA塔泽莫斯托stat与R-CHOP联合治疗新诊断弥漫性大B细胞淋巴瘤老年患者的疗效:LYSA的EpiRCHOP II期研究结果
err2025-04-01
err0
PREAI
errSarkozy, Clementine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cedric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stephanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent
err分享
err收藏
Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphoma淋巴瘤中嵌合抗原受体修饰的T(CAR-T)细胞疗法中的淋巴细胞清除化疗
err2025-03-27
err0
errOAAI
errCanelo-Vilaseca, Marta; Sabbah, Mohamad; Di Blasi, Roberta; Cristinelli, Caterina; Sureda, Anna; Caillat-Zucman, Sophie; Thieblemont, Catherine
err分享
err收藏
Fatty Acid Metabolism Provides an Essential Survival Signal in OxPhos and BCR DLBCL Cells
err2025-03-13
err0
errOAAI
errMontagne, Aurelie; Kotta, Konstantina; Kielbassa-Elkadi, Karoline; Martins, Isabelle; Martinez-Climent, Jose angel; Kroemer, Guido; Thieblemont, Catherine; Baud, Veronique
err分享
err收藏
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell LymphomaNGS检测到的TP53突变是分层套细胞淋巴瘤的主要临床风险因素
err2025-03-06
err0
PREAI
errLazarian, G; Chemali, L; Bensalah, M; Zindel, C; Lefebvre, V; Thieblemont, C; Martin, A; Tueur, G; Letestu, R; Fleury, C; Leymarie, V; Vidal, V; Bidet, A; Maitre, E; Cymbalista, F; Levy, V; Soussi, T; Baran-Marszak, F
err分享
err收藏